Oct. 23 at 2:41 PM
$CLRB The sharp decline in the share price in recent days is in line with the original market capitalization prior to the capital increase.... According to the latest SEC filing, there are now 6,336,322 shares "outstanding" (including the two convertible bonds).
This means that at a share price of
$3.90 x 6.34 million shares = approx.
$25.0 million market capitalization.
Before the capital increase and the good news from the EMA ("go" EU filing), the share price was USD 6.0 x 3.3 million shares = USD 20.0 million market capitalization. So we should now be at roughly the same market capitalization plus a small revaluation of USD +5 million, if it stays that way!
Ultimately, the share price already factors in the +2.0 million convertible shares at
$6, even though these have not yet been exercised.
I hope the storm is over an we get the LTE-data on iopofosine in WM for the FDA!!
